Geroprotective Interventions Preserve Trabecular Bone During Ageing In Female Mice
As we age, our bones can become weaker, a condition that affects many, especially women. Researchers have been exploring new ways to combat this age-related bone loss, looking beyond traditional treatments. A recent study investigated the effects of certain “geroprotectors”—compounds known to extend lifespan and improve overall health—on bone health in aging mice.
The study focused on two main types of bone: trabecular bone, which is the spongy, inner part of our bones crucial for strength, and cortical bone, the dense outer layer. The findings revealed that several of these geroprotective interventions, including rapamycin, acarbose, and 17α-estradiol, significantly helped preserve trabecular bone in older female mice. This preservation was mainly due to an increase in the number of tiny, rod-like structures within the trabecular bone, rather than an increase in their thickness.
Interestingly, these beneficial effects were predominantly observed in female mice, with very little impact on males. While the effects on cortical bone were less pronounced, these results suggest that these compounds could offer a promising new approach to maintaining bone health as we age, particularly for women. This research opens doors for developing therapies that not only target bone loss but also contribute to overall healthy aging.
Source: link to paper